Next, the panelists dig into why “efficacy” claims cannot be compared apples-to-apples. Before the pandemic, researchers showcased wildly different test methods, including carrier materials and inoculum, device-to-surface distance, exposure time, and the log-reduction targets, making it difficult for clinicians to interpret results across UV systems. Our panelist explains how that inconsistency pushed her to scrutinize study design and ultimately partner with one of the FDA-cleared device makers.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.